Gastrointestinal (GI) medical oncology with a clinical research interest in pancreatic and hepatobiliary cancers; Early phase I drug development and GI focused phase II clinical trials
BS Honors: Vanderbilt University, 2001; MD: The University of Texas Health Science Center, 2005; Resident: Vanderbilt University, 2005-2008; Fellowship: University of North Carolina, 2008-2011; Assistant Professor of Medicine: University of North Carolina, 2011-2016; Associate Professor of Medicine, 2016-present.
Dr. McRee is a GI medical oncologist with a clinical research interest in early phase drug development and clinical trials. She has established a translational research focus at UNC in pancreatic and hepatobiliary cancers with strong collaborations within the Lineberger Comprehensive Cancer Center (LCCC), specifically in tissue-based research, next generation sequencing and bioinformatics. She has served as PI on approximately 20 clinical trials, six being investigator initiated trials that she developed in collaboration with her lab colleagues. She chairs the Protocol Review Committee (PRC) at UNC and is the Director of the GI Clinical Trials POD. Nationally, she serves as Co-Chair of the Hoosier Cancer Research Network (HCRN) GI Clinical Trials Working Group and the UNC site-PI for the Academic and Community Cancer Research United (ACCRU) consortium.